GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to beco ...

GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board."We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtroni ...

Core Viewpoint - Medtronic plc will participate in Bernstein's 41st Strategic Decisions Conference on May 29, 2025, where CEO Geoff Martha will present and answer questions alongside CFO Thierry Piéton [1][2]. Company Overview - Medtronic is a leading global healthcare technology company headquartered in Galway, Ireland, with a mission to alleviate pain, restore health, and extend life [4]. - The company employs over 95,000 people across more than 150 countries and addresses 70 health conditions through various technologies and therapies, including cardiac devices, surgical robotics, and patient monitoring systems [4]. - Medtronic aims to deliver innovative technologies that transform lives, impacting two people every second [4]. Event Details - The presentation by CEO Geoff Martha will begin at 11:00 a.m. EDT on May 29, 2025, followed by a Q&A session with CFO Thierry Piéton [2]. - A live webcast of the event will be available on Medtronic's investor relations website, with an archive accessible later the same day [3].

Core Insights - Medtronic plc will report its financial results for the fourth quarter and full fiscal year 2025 on May 21, 2025, with a news release at approximately 5:45 a.m. CDT [1] - A video webcast will be held at 7:00 a.m. CDT on the same day to discuss the financial results, with a replay and transcript available within 24 hours [2] - Looking ahead, Medtronic plans to report its quarterly results for fiscal year 2026 on August 19, November 18, February 17, and May 20 of the respective years [3] Company Overview - Medtronic, headquartered in Galway, Ireland, is a leading global healthcare technology company focused on addressing significant health challenges through innovative solutions [4] - The company employs over 95,000 people across more than 150 countries and offers technologies that treat 70 health conditions, including cardiac devices, surgical robotics, and patient monitoring systems [4] - Medtronic's mission is to alleviate pain, restore health, and extend life, emphasizing a commitment to delivering transformative healthcare solutions [4]

Core Insights - Medtronic's "Letter to My Mother" campaign aims to raise awareness about heart health among women, particularly focusing on the importance of discussing family health history and risk factors [4][13] - A survey conducted by Medtronic reveals a significant gap in awareness and discussions about heart health among women aged 30-50, despite cardiovascular disease being the leading cause of death for women in the U.S. [1][3] Survey Findings - Nearly half of the women (45%) are more likely to discuss sensitive topics like politics or money with their mothers than family heart health history, despite hereditary risks [2] - Over half (56%) of women have never discussed heart health with their mothers or family members, and only one-third (35%) of those with a family history of heart disease have consulted their doctors about their heart risk [7][8] - 53% of women worry that their aging mothers may ignore symptoms of heart disease, yet only 44% have actually talked about heart health with them [7][8] Health Disparities - Women are 35% less likely than men to receive treatment for heart valve failure, and they account for 52% of deaths caused by high blood pressure [3] - Heart disease disproportionately affects women of color, with 43% of Hispanic women and 59% of Black women experiencing some form of cardiovascular disease [3] Campaign Objectives - The campaign encourages women to prioritize heart health by initiating conversations about family history and risk factors [4][13] - Medtronic aims to close the awareness gap regarding heart disease, particularly focusing on high blood pressure and heart valve failure [4][13] Company Commitment - Medtronic is dedicated to improving health outcomes for women through personalized, evidence-based healthcare solutions [5] - The company is actively promoting awareness and advocacy for women's heart health, as evidenced by their partnership with WomenHeart [12]